Market Report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Spain", published

GlobalData, the industry analysis specialist, has released its new report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Spain". The report is an essential source of information and analysis on Spain's healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory and reimbursement landscape and the country's healthcare infrastructure. Most importantly, it provides valuable insights into the trends and segmentation of the Spanish pharmaceutical and medical device markets. The report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.

Full Report Details at
- http://www.fastmr.com/prod/642934_countryfocus_healthcare_regulatory_and.aspx?afid=303

Spain's population was 47.1 million in 2012, but it is decreasing due to a negative balance between the birth and death rate, as well as a negative migration balance. The country's policymakers are currently faced with the challenge of an increasing unemployment rate due to a lack of clear monetary policies. The pharmaceutical market at the pharmacy retail price was estimated to be worth $24.8 billion in 2012, and is expected to reach $29.4 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 0.6%. The medical devices market was estimated at approximately $7 billion in 2012, and is expected to reach $11.9 billion by 2020 at a CAGR of 4.8%.

Scope

The report provides information on Spain's healthcare, regulatory and reimbursement landscape, and includes -

* An overview of the pharmaceutical and medical devices markets, comprising size, segmentation and key drivers and barriers
* Profiles and SWOT analyses of the major players in the pharmaceutical market, comprising Pfizer, F. Hoffmann-La Roche, Novartis, Sanofi and Eli Lilly; and medical devices market, comprising Abbott Laboratories, F. Hoffmann-La Roche, Medtronics, GE Healthcare and Siemens Healthcare
* An insightful review of the country's reimbursement and regulatory landscape, including details of the healthcare reimbursement process, regulatory agencies and approval processes for new drugs
* Detailed analysis of the political and economic environment, including economic indicators, demographics, and healthcare infrastructure and expenditure
* An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to Get this Report

This report will enhance your decision-making capability by allowing you to -

* Develop business strategies by understanding the trends shaping and driving Spain's healthcare market
* Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact Spain's healthcare market in the future

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France
- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy
- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - US
- Healthcare, Regulatory and Reimbursement Landscape - Germany
- Healthcare, Regulatory and Reimbursement Landscape - Spain